Distribution of risk factors in the 27 relatives with VTE
| . | Wild-type (n = 0) . | Homozygous PT20210 (n = 3) . | Heterozygous FVL (n = 10) . | Homozygous PT20210 (n = 1) . | Homozygous FVL (n = 11) . | Combined polymorphisms (n = 2) . |
|---|---|---|---|---|---|---|
| No risk factor, n (%) | –– | 1 (33) | 5 (50) | 1 (100) | 3 (27) | 2 (100) |
| M/F | –– | 0/1 | 2/3 | 0/1 | 2/1 | 2/0 |
| Surgery, trauma or immobilization, n (%) | –– | 1 (33) | 2 (20) | –– | 1 (9) | –– |
| M/F | –– | 1/0 | 1/1 | –– | 0/1 | –– |
| Pregnancy/puerperium, n (%)* | –– | 1 (50) | –– | –– | 2 (25) | –– |
| Oral contraceptive use, n (%)* | –– | –– | 3 (43) | –– | 5 (63) | –– |
| . | Wild-type (n = 0) . | Homozygous PT20210 (n = 3) . | Heterozygous FVL (n = 10) . | Homozygous PT20210 (n = 1) . | Homozygous FVL (n = 11) . | Combined polymorphisms (n = 2) . |
|---|---|---|---|---|---|---|
| No risk factor, n (%) | –– | 1 (33) | 5 (50) | 1 (100) | 3 (27) | 2 (100) |
| M/F | –– | 0/1 | 2/3 | 0/1 | 2/1 | 2/0 |
| Surgery, trauma or immobilization, n (%) | –– | 1 (33) | 2 (20) | –– | 1 (9) | –– |
| M/F | –– | 1/0 | 1/1 | –– | 0/1 | –– |
| Pregnancy/puerperium, n (%)* | –– | 1 (50) | –– | –– | 2 (25) | –– |
| Oral contraceptive use, n (%)* | –– | –– | 3 (43) | –– | 5 (63) | –– |
Percentage calculated on the number of women.